Clinical Breast Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.7 | Q3 | 44.7% | 0.932 | Q2 | 81.9% |
| 2024 | 2.5 | Q3 | 42.6% | 1.018 | Q2 | 84.7% |
| 2023 | 2.9 | Q2 | 50.4% | 0.942 | Q2 | 84.0% |
| 2022 | 3.1 | Q3 | 45.1% | 0.862 | Q2 | 82.6% |
| 2021 | 3.1 | Q4 | 43.3% | 0.824 | Q2 | 81.9% |
| 2020 | — | — | 1.078 | Q2 | 86.9% | |
| 2019 | — | — | 1.142 | Q2 | 88.3% | |
| 2018 | — | — | 1.068 | Q2 | 85.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1938-0666
ISSN
1526-8209
country
UScoverage
2000-2026